Companies to implement the spirit of the city's private economic development conference
Release time:
2022-02-21
News from our newspaper # February 8 , Jinhua city held a conference on the development of private economy and advanced manufacturing industry. The group company office meeting held on 9 conveyed and learned the spirit of the conference, and made targeted arrangements for some of the company's key work in 2022 . Jiang Xiaomeng, chairman of
Group Company, attended the conference and received commendation as the honorary winner of "Fengyun Zhejiang Merchants" of the year. When talking about the experience of attending the meeting, he said that the conference on the development of private economy and advanced manufacturing industry is the first conference after the new year, which fully reflects the importance attached by the municipal Party committee and the municipal government to the development of private economy and advanced manufacturing industry. As a veteran enterprise of Jinhua, Jianfeng has adhered to industry for more than 60 years, and the two main businesses of cement and medicine are in fully competitive industries. If you want to stand out in the fierce market competition, you must take the initiative to study the general trend of economic development at home and abroad and the country's industrial policies, find out your own position and direction of efforts, especially in scientific and technological innovation and digital transformation of traditional industries, and constantly optimize product structure, talent team and management mode, further consolidate the industrial foundation, establish competitive advantages, fundamentally promote the transformation and upgrading of traditional industries, and embark on a high-quality development path in line with the future growth of enterprises.
According to the requirements put forward in the meeting, such as "promoting large-scale space reconstruction, industrial renovation, digital reform, project recruitment, innovation drive and policy sorting", Jinhua's existing industrial park platform will systematically sort out, check the land use and per mu yield contribution of enterprises entering the park, and raise the standard requirements, the direction of support policies for enterprises will also be adjusted. For this reason, the group office meeting proposed to fully promote the construction of established key projects for some key tasks in 2022 , comprehensively revise and improve the internal control management system according to the current situation of the company, strengthen the inspection and supervision of the implementation of the internal control management system, strengthen the collection and research of policy information, strive to improve the profitability of subordinate enterprises, strengthen the construction of information talent team, and improve the informatization and digitalization work level of the company, strengthen the education, guidance and supervision of management personnel and risk positions, and create a thoughtful, passionate, motivated, and clean team atmosphere and other work requirements. The meeting also asked all enterprises to do their best to do a good job in the production and operation of enterprises, seek development through innovation, win the market with products, and strive to achieve a good start in the first quarter of 2022 , so as to contribute to Jinhua's private economy's "striving for the first place in carrying the flag and rising in central Zhejiang.
(Reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page